Medical research

New drug target for Ebola, Marburg viruses

Ebola and Marburg are among the most deadly viruses, with mortality rates from these infections ranging from 25% to 90%. While no drugs currently are available on the market to prevent infection from these viruses—they ...

Diseases, Conditions, Syndromes

Researchers show how Ebola virus hijacks host lipids

Robert Stahelin studies some of the world's deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates. Stahelin, professor at Purdue University, examines ...

Diseases, Conditions, Syndromes

Ebola expert weighs in on news of a potential cure

Scientists recently reported that two treatments saved the lives of people infected with the Ebola virus—with the New York Times reporting that roughly 90% of newly infected patients were saved—suggesting we are ever ...

Diseases, Conditions, Syndromes

US approves dengue vaccine Dengvaxia

US health authorities have given their approval to dengue vaccine Dengvaxia, the controversial first treatment designed to protect against the deadly mosquito-borne virus.

Diseases, Conditions, Syndromes

Viral decoys—how the Ebola virus leads the immune system astray

A research team from Tübingen and Göttingen has described in the renowned journal Cell Reports a new mechanism how the Ebola virus escapes the immune system. The virus causes infected cells to release decoys that inactivate ...

Diseases, Conditions, Syndromes

Triazavirin defeats tick-borne encephalitis

The drug triazavirin, developed by the researchers of the Ural Branch of the Russian Academy of Sciences and the Institute of Chemical Engineering of Ural Federal University, has proved to be an effective remedy against tick-borne ...

Diseases, Conditions, Syndromes

Zika may hijack mother-fetus immunity route

To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

page 2 from 8